Atlas Trials

Palonosetron Versus Ondansetron for PONV Prevention in Patients Undergoing ERCP

Clinical trial NCT04576390 · UNKNOWN

Trial details

NCT number
NCT04576390
Sponsor
Theodor Bilharz Research Institute
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
AntiemeticPostoperative Nausea and Vomiting
Start date
2020-10-24
Primary completion
2021-04-30
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.